Affiliation:
1. Chaoyang Central Hospital,China Medical University
2. Department of Gastrointestinal Surgery, Chaoyang Central Hospital
3. Department of Gastrointestinal Surgery,Chaoyang Central Hospital Postgraduate Training Base, Jinzhou Medical University
4. Chengde Medical University
Abstract
Abstract
Objective
This study aims to analyze the risk factors for Cancer-Specific Mortality (CSM) and Other-Cause Mortality (OCM) in early-onset colorectal cancer (EOCRC) patients,and to construct a nomogram for predicting CSM based on a competitive risk model and validate it using training, internal, and external cohorts.
Methods
EOCRC patients from the SEER database(2008–2017). Furthermore, EOCRC patients treated at a Northeast China tertiary hospital were included(2014–2020). The SEER data were randomly divided into training and validation sets at a 7:3 ratio. Univariate COX regression model was used to screen for prognostic correlates. Multivariate Cox regression models were then employed to identify independent risk factors. A nomogram visualized results, assessed by C-index,AUC and calibration curves. DCA evaluated clinical utility.
Results
A total of 8,813 patients were collected from the SEER database, divided into training (N = 6,610) and validation (N = 2,203) sets. 76 patients were included from the Chinese cohort(N = 76). Multivariable Cox regression models revealed that race, tumor differentiation, carcinoembryonic antigen (CEA), marital status, histological type, AJCC stage, and surgical status were independent risk factors for CSM in EOCRC patients. The nomogram constructed based on those independent risk factors had good performance with C-index of 0.806 ,0.801and 0.810 for the training, internal validation and external validation cohorts, respectively.Calibration curves and AUC also indicated the nomogram's accuracy and discriminative ability. Also DCA reflects the good clinical value of the model.
Conclusion
This study successfully established a competing risk model for CSM in EOCRC patients, demonstrating good predictive value, which may help clinicians to make better treatment decision making.
Publisher
Research Square Platform LLC
Reference46 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021
2. Colorectal cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023
3. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection;Patel SG;Lancet Gastroenterol Hepatol,2022
4. Early-onset colorectal cancer: initial clues and current views;Hofseth LJ;Nat Rev Gastroenterol Hepatol,2020
5. Cancer treatment and survivorship statistics, 2022;Miller KD;CA Cancer J Clin,2022